Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
This study has been terminated.
Study NCT00275379   Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received on January 9, 2006.   Last Updated on March 14, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystitis, Interstitial
Additional conditions recognized in this trial
Cystitis
More general conditions related to this trial
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
ERB-041
Sponsors listed in this trial
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services